HIGHLIGHTS
- who: Boglu00e1rka Szalai and collaborators from the Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of have published the research: Design and Optimization of In Situ Gelling Mucoadhesive Eye Drops Containing Dexamethasone, in the Journal: Gels 2022, 8, 561. of /2022/
SUMMARY
Bypassing the complex defense mechanisms of the eye and thus achieving effective ocular drug delivery poses challenges for pharmaceutical technologists. Permeability through the cornea is limited as eye drops are eliminated from the site of application within minutes due to overflow, nasolacrimal drainage, blinking, and increased tear production . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.